Original podcast published by HIMSS Accelerate Health Podcast on June 30, 2021
We are in the midst of a digital transformation. Digital health innovation has the potential to change healthcare and the pharmaceutical industry. Yet, we aren’t seeing many successful deals between pharma and digital health startups. In this HIMSS Accelerate Health podcast, Kerry Amato interviews Naomi Fried PhD, founder and CEO of PharmStars, a recently launched pharma-focused digital health accelerator. Naomi describes the “pharma-startup gap”, the chasm that exists between big pharma and digital health startups, preventing more successful partnerships. Naomi also discusses how PharmStars plans to bridge the gap, yielding more successful deals and improved outcomes for patients.
PharmStars™ is the first and only non-proprietary pharma-focused accelerator for digital health startups. Through our extensive expertise across pharma, startups, digital health, and innovation, we understand the challenges that pharma and startups face when seeking to collaborate. Our PharmaU™ program supports digital health startups and our pharma members in "bridging the gap," leading to greater success and faster adoption of "beyond the molecule" solutions for patients. www.PharmStars.com